Performance of idarucizumab as antidote of dabigatran in daily clinical practice

SJ van der Wall, N van Rein, B van den Bemt, Marieke Kruip, K Meijer, LCJ te Boome, TA Simmers, AM Alings, R Tieleman, PE Westerweel, F Klok, M Huisman

Research output: Contribution to journalArticleAcademicpeer-review

34 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)414-420
Number of pages7
Issue number3
Publication statusPublished - 2019

Research programs

  • EMC COEUR-09

Cite this